ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Emory University
- Study ID
- NCT07559903
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Coronary Artery Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- May 31, 2031
- Completion
- May 31, 2031
Study Design
- Enrollment
- 5,000 participants (estimated)
Arms
- Arm: Adults undergoing PCI with drug-coated balloons (DCB) for de novo coronary artery diseaseAll adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Primary Outcome Measure
Incidence of Target Lesion Failure (TLF) [ Time Frame: At hospital discharge, 30 days, 6 months, and 12 months post-discharge, then yearly up to 5 years post-discharge ]
Central Contacts
- Daniel Gold, MD314-761-3396
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner University Medical Center | Phoenix | Arizona | 85006 | - |
| Emory Saint Joseph's Hospital | Atlanta | Georgia | 30342 | - |
| Emory University Hospital | Atlanta | Georgia | 30322 | - |
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | - |
| Emory Johns Creek Hospital | Johns Creek | Georgia | 30097 | - |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Kevin Croce |
| Tufts Medical Center | Boston | Massachusetts | 02111 | Imran Aslam |
| Allina Health Minneapolis Heart Institute | Minneapolis | Minnesota | 55407 | Manos Brilakis |
| Montefiore Medical Center | New York | New York | 10467 | Azeem Latib Louis Verreault-Julien (SUB_INVESTIGATOR) Pier Pasquale Leone (SUB_INVESTIGATOR) |
| New York-Presbyterian/Weill Cornell Medical Center | New York | New York | 10065 | Jai Khatri |
| The Mount Sinai Hospital | New York | New York | 10029 | Shamin Sharma |
| St. Francis Hospital & Heart Center | Roslyn | New York | 11576 | Ziad Ali |
| Sanger Heart & Vascular Institute | Charlotte | North Carolina | 28203 | Nyal Borges |
| Duke University Hospital | Durham | North Carolina | 27707 | Mariem Sawan |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | Bernardo Cortese |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Leah Raj |
Find similar trials in Phoenix, AZ
Related Studies
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Is Our Microbiome a Predictor of Cardiac RiskEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Randomization of Single vs Multiple Arterial GraftsRecruiting · Weill Medical College of Cornell University · Boulder, Colorado
- Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenRecruiting · Weill Medical College of Cornell University · Los Angeles, California